Published in Hepatitis Weekly, May 3rd, 2010
"Previous studies showed that the HCV core antigen (HCV Ag) may be an alternative to HCV RNA in this context. To evaluate the performances of the new Abbott ARCHITECT(®) HCV Ag test and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.